| |
About Us
GlycoBioSciences is a pharmaceutical company exclusively devoted to the sale, licensing and development of our IPM (Ionic Polymer Matrix) technology and products. Our technology is covered by ten in force US patents and 1 UK patent. Currently we have licensed one of our products (IPM Wound Gel) to ECR Pharmaceutical a company owned by Hi Tech Pharmacal (NASDAQ-HITK) and expect it to be launched in the US in September 2011, the IPM Wound Gel has been approved for sale in the US by the FDA under approval K020325.
We are also currently launching for sale our anti aging product (Glyco HA) and continue to work on the development of our other products (Diclofenac Pain Gel, Sexual Dysfunction Gel, and Eczema Gel) along with developing other products for further use of our IPM delivery technology. |
|
